Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Not Applicable

• Conditions: -J44 Other chronic obstructive pulmonary disease; Other chronic obstructive pulmonary disease; J44

• Registration Number: PER-028-04
• Lead Sponsor: OVARTIS BIOSCIENSES PERU S.A.,

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2004-07-08
• Last Update Posted: 4 September 2023

Recruitment & Eligibility

• Status: Complete
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Diagnosis of COPD
Age 40-75 years
Smoking history

Exclusion Criteria

Other serious disease
Allergy to QAB149
Respiratory tract infection

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br>Outcome name:Pulmonary function<br>Measure:Pulmonary function is measured between 22 and 24 hours after dosing on day 1.<br>Timepoints:22 and 24 hours<br>

Secondary Outcome Measures

Name	Time	Method
<br>Outcome name:Pulmonary function<br>Measure:Pulmonary function measured on days 1 and 7 at different intervals after dosing<br>Timepoints:days 1 and 7<br>